{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:08:19Z","timestamp":1785514099625,"version":"3.56.0"},"reference-count":71,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2015.01009","type":"journal-article","created":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T09:38:56Z","timestamp":1443433136000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Anthrax prophylaxis: recent advances and future directions"],"prefix":"10.3389","volume":"6","author":[{"given":"E. Diane","family":"Williamson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward Hugh","family":"Dyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1000792","DOI":"10.1371\/journal.ppat.1000792","article-title":"Endocytosis of the anthrax toxin is mediated by clathrin, actin and unconventional adaptors","volume":"6","author":"Abrami","year":"2010","journal-title":"PLoS Pathog"},{"key":"B2","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.celrep.2013.10.019","article-title":"Hijacking multivesicular bodies enables long-term and exosome-mediated long-distance action of anthrax toxin","volume":"5","author":"Abrami","year":"2013","journal-title":"Cell Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1083\/jcb.200507067","article-title":"Receptor palmitoylation and ubiquination regulate anthrax toxin endocytosis","volume":"172","author":"Abrami","year":"2006","journal-title":"J. Cell Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tim.2004.12.004","article-title":"Anthrax toxin: the long and winding road that leads to the kill","volume":"13","author":"Abrami","year":"2005","journal-title":"Trends Microbiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1128\/IAI.00261-07","article-title":"Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax","volume":"75","author":"Albrecht","year":"2007","journal-title":"Infect Immun."},{"key":"B6","volume-title":"United States Patent US 3208909","author":"Anthrax Vaccine Adsorbed","year":"1965"},{"key":"B7","author":"Anthrax ACIP Vaccine Recommendations","year":"2001"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1004085","DOI":"10.1371\/journal.ppat.1004085","article-title":"Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity","volume":"10","author":"Ascough","year":"2014","journal-title":"PLoS Pathog."},{"key":"B9","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/toxins4100878","article-title":"Anthrax lethal toxin and the induction of CD4 T cell immunity","volume":"4","author":"Ascough","year":"2012","journal-title":"Toxins"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.1016\/j.vaccine.2010.07.075","article-title":"An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor","volume":"28","author":"Baillie","year":"2010","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/1560-7917.es2014.19.32.20877","article-title":"Injectional anthrax-new presentation of an old disease","volume":"19","author":"Berger","year":"2014","journal-title":"Eurosurveillance"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1128\/IAI.00070-07","article-title":"Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge","volume":"75","author":"Bielinska","year":"2007","journal-title":"Infect Immun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"20130427","DOI":"10.1098\/rstb.2013.0427","article-title":"The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis","volume":"369","author":"Blankley","year":"2014","journal-title":"Phil. Trans. R. Soc. B"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizingantibodies and Th cell responses following nasal immunization with protective antigen1","volume":"170","author":"Boyaka","year":"2003","journal-title":"J. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1007\/s00216-015-8509-5","article-title":"High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasures","volume":"407","author":"Boyer","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1128\/IAI.00346-09","article-title":"Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques","volume":"77","author":"Boyer","year":"2009","journal-title":"Infect. Immun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1021\/ac701741s","article-title":"Detection and quantification of anthrax lethal factor in serum by mass spectrometry","volume":"79","author":"Boyer","year":"2007","journal-title":"Anal. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/IAI.70.2.661-664.2002","article-title":"Anthrax spores make an essential contribution to vaccine efficacy","volume":"70","author":"Brossier","year":"2002","journal-title":"Infect. Immun"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1128\/CVI.00469-14","article-title":"Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques","volume":"21","author":"Chen","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/toxins3081004","article-title":"Monoclonal antibody therapies against anthrax","volume":"3","author":"Chen","year":"2011","journal-title":"Toxins"},{"key":"B21","doi-asserted-by":"publisher","first-page":"475809","DOI":"10.1155\/2013\/475809","article-title":"A human\/murine chimeric fab antibody neutralizes anthrax lethal toxin in vitro","volume":"2013","author":"Ding","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1128\/IAI.00764-08","article-title":"Association of Bacillus anthracis capsule with lethal toxin during experimental infection","volume":"77","author":"Ezzell","year":"2009","journal-title":"Infect. Immun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004073","article-title":"Anthrax vaccine\u2013induced antibodies provide cross-species prediction of survival to aerosol challenge","volume":"4","author":"Fay","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1128\/IAI.70.4.2022-2028.2002","article-title":"Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice","volume":"70","author":"Flick-Smith","year":"2002a","journal-title":"Infect Immun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection","volume":"70","author":"Flick-Smith","year":"2002b","journal-title":"Infect. Immun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"D28","DOI":"10.1016\/j.vaccine.2009.08.102","article-title":"Advances in the development of next-generation anthrax vaccines","volume":"27","author":"Friedlander","year":"2009","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nature09446","article-title":"Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11\/Sec15 exocyst","volume":"467","author":"Guichard","year":"2010","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micinf.2011.08.016","article-title":"New insights into the biological effects of anthrax toxins: linking cellular to organismal responses","volume":"20","author":"Guichard","year":"2011","journal-title":"Microb. Infect."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6089","DOI":"10.1016\/j.vaccine.2007.05.018","article-title":"Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine","volume":"25","author":"Hepburn","year":"2007","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/cei.12090","article-title":"Exposure to anthrax toxin alters human leucocyte expression of anthrax toxin receptor 1","volume":"173","author":"Ingram","year":"2013","journal-title":"Clin. Exp. Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.4049\/jimmunol.0901581","article-title":"Natural exposure to cutaneous anthrax gives long-lasting t cell immunity encompassing infection-specific epitopes","volume":"184","author":"Ingram","year":"2010","journal-title":"J. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1128\/CVI.00099-13","article-title":"Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis","volume":"20","author":"Ionin","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1128\/IAI.01145-10","article-title":"The poly-y-D-glutamic acid capsule of Bacillus anthracis enhances lethal toxin activity","volume":"79","author":"Jang","year":"2011","journal-title":"Infect. Immun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg. Infect. Dis"},{"key":"B35","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3201\/eid0810.020353","article-title":"Investigation of bioterrorism-related anthrax, United, States (2001): epidemiologic findings","volume":"8","author":"Jernigan","year":"2002","journal-title":"Emerg. Inf. Dis"},{"key":"B36","volume-title":"Beitrage zur Biologie der Pflanzen.","author":"Koch","year":"1876"},{"key":"B37","doi-asserted-by":"publisher","first-page":"13147","DOI":"10.1073\/pnas.0405405101","article-title":"Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation","volume":"101","author":"Lacy","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1128\/CVI.00240-12","article-title":"rPA vaccine improves survival when administered as a post-exposure prophylaxis countermeasure with antibiotics, in the New Zealand white rabbit model of inhalation anthrax","volume":"19","author":"Leffel","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.1128\/IAI.73.10.6547-6551.2005","article-title":"An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin","volume":"73","author":"Lim","year":"2005","journal-title":"Infect. Immun"},{"key":"B40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1099\/13500872-142-3-707","article-title":"Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies","volume":"142","author":"Little","year":"1996","journal-title":"Microbiology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1517\/14712598.3.5.843","article-title":"Anthrax toxin: structures, functions and tumour targeting","volume":"3","author":"Liu","year":"2003","journal-title":"Expert Opin. Biol. Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1128\/AAC.02295-13","article-title":"Efficacy and safety of AVP-21D9, an anthrax monoclonal antibody, in animal models and humans","volume":"58","author":"Malkevich","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"15583","DOI":"10.1073\/pnas.1010145107","article-title":"Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin","volume":"107","author":"Martchenko","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.7973702","article-title":"The Sverdlovsk anthrax outbreak of 1979","volume":"266","author":"Meselson","year":"1994","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"6847","DOI":"10.1016\/j.vaccine.2014.01.096","article-title":"Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909)","volume":"32","author":"Minang","year":"2014","journal-title":"Vaccine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mib.2003.12.001","article-title":"The roles of anthrax toxin in pathogenesis","volume":"7","author":"Moayeri","year":"2004","journal-title":"Curr. Opin. Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1073\/pnas.0900029106","article-title":"Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge","volume":"106","author":"Mohamadzadeh","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1128\/IAI.01722-07","article-title":"Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant","volume":"76","author":"Park","year":"2008","journal-title":"Infect. Immun"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3201\/eid0810.020444","article-title":"Public Health in the time of bioterrorism","volume":"8","author":"Perkins","year":"2002","journal-title":"Emerg. Inf. Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1086\/644506","article-title":"Encapsulated Bacillus anthracis interacts closely with liver endothelium","volume":"200","author":"Piris-Gimenez","year":"2009","journal-title":"J. Infect. Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1086\/523578","article-title":"Countering anthrax vaccines and immunoglobulins","volume":"46","author":"Plotkin","year":"2008","journal-title":"J. Infect. Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1128\/IAI.01328-12","article-title":"Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays","volume":"81","author":"Pohl","year":"2013","journal-title":"Infect. Immun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1128\/IAI.00275-06","article-title":"Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival","volume":"74","author":"Ribot","year":"2006","journal-title":"Infect. Immun"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1128\/CVI.05059-11","article-title":"Phase I study evaluating the safety and pharmacokinetics of MDX-1303, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteers","volume":"18","author":"Riddle","year":"2011","journal-title":"Clin. Vaccine Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e1003264","DOI":"10.1371\/journal.ppat.1003264","article-title":"Relative contribution for Th1 and Th17 cells in a adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine","volume":"9","author":"Ross","year":"2013","journal-title":"PLoS Pathog."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1016\/j.vaccine.2015.05.091","article-title":"Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans","volume":"33","author":"Schiffer","year":"2015","journal-title":"Vaccine"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3201\/eid0810.020349","article-title":"Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence","volume":"8","author":"Shepard","year":"2002","journal-title":"Emerg. Infect. Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1078\/1438-4221-00147","article-title":"Dicovery of the anthrax toxins: the beginning of studies of virulence factors regulated in vivo","volume":"291","author":"Smith","year":"2002","journal-title":"Int. J. Med. Microbiol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.mam.2009.06.001","article-title":"The adenylyl cyclase activity of anthrax edema factor","volume":"30","author":"Tang","year":"2009","journal-title":"Mol. Aspects Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e109720","DOI":"10.1371\/journal.pone.0109720","article-title":"Specific activation of dendritic cells enhances clearance of Bacillus anthracis following Infection","volume":"9","author":"Thompson","year":"2014","journal-title":"PLoS ONE."},{"key":"B62","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.mam.2009.06.002","article-title":"Anthrax toxins: a weapon to systematically dismantle the host immune defences","volume":"30","author":"Tournier","year":"2009","journal-title":"Mol. Aspects Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.4049\/jimmunol.174.8.4934","article-title":"Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells","volume":"174","author":"Tournier","year":"2005","journal-title":"J. Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bios.2012.05.012","article-title":"Electrochemical detection of the binding of Bacillus anthracis protective antigen (PA) to the membrane receptor on macrophages through release of nitric oxide","volume":"38","author":"Trouillon","year":"2012","journal-title":"Biosens. Bioelectron."},{"key":"B65","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/0264-410X(91)90237-Z","article-title":"Anthrax vaccines, past, present and future","volume":"9","author":"Turnbull","year":"1991","journal-title":"Vaccine"},{"key":"B66","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.mam.2009.08.007","article-title":"Receptors of anthrax toxin and cell entry","volume":"30","author":"van der Goot","year":"2009","journal-title":"Mol. Aspects Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.cell.2005.12.045","article-title":"The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin","volume":"124","author":"Wei","year":"2006","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.1128\/IAI.73.9.5978-5987.2005","article-title":"Immunogenicity of recombinant Protective Antigen and efficacy against aerosol challenge with anthrax","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect. Immun."},{"key":"B69","volume-title":"Anthrax in Humans and Animals, 4th Edn","author":"World Health Organization","year":"2008"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.vaccine.2013.10.039","article-title":"Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial","volume":"32","author":"Wright","year":"2014","journal-title":"Vaccine"},{"key":"B71","first-page":"1","article-title":"Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2000","volume":"59","author":"Wright","year":"2010","journal-title":"MMWR Recomm. Rep"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T20:21:04Z","timestamp":1498249264000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2015.01009\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,24]]},"references-count":71,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2015.01009","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,24]]}}}